HEPATITIS B ANTIVIRAL AGENTS
First Claim
1. A compound represented by Formula (I):
-
X-A-Y-L-R
(I),or a pharmaceutically acceptable salt thereof, wherein;
X and Y are each independently selected from optionally substituted aryl and optionally substituted heteroaryl;
A is selected from the group consisting of —
NHC(O)—
,
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:
X-A-Y-L-R (I)
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
19 Citations
15 Claims
-
1. A compound represented by Formula (I):
-
X-A-Y-L-R
(I),or a pharmaceutically acceptable salt thereof, wherein; X and Y are each independently selected from optionally substituted aryl and optionally substituted heteroaryl; A is selected from the group consisting of —
NHC(O)—
, - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
Specification